Allergen‐Specific <scp>IgE</scp> is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years
Findings do not support age as an independent predictor of remission following OIT. Additional studies examining safety and efficacy of OIT in infants and younger children are urgently needed, ahead of widespread adoption of early intervention.
Authors
- Adriana Chebar Lozinsky (ORCID: https://orcid.org/0000-0002-6765-2762)
- Mimi L.K. Tang (ORCID: https://orcid.org/0000-0002-3839-5293)
- Michael O’Sullivan (ORCID: https://orcid.org/0000-0001-7896-2697)
- Melanie Lloyd (ORCID: https://orcid.org/0000-0002-3889-5458)
- Paxton Loke (ORCID: https://orcid.org/0000-0002-9474-083X)
- Francesca Orsini (ORCID: https://orcid.org/0000-0001-5183-5946)
- Michael Gold (ORCID: https://orcid.org/0000-0002-4410-1669)
- Sarah Ashley (ORCID: https://orcid.org/0000-0001-9973-9742)
- Patrick Quinn
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- The Kids Research Institute Australia (AU)
- The University of Western Australia (AU)
- Princess Margaret Hospital for Children (AU)
- Monash Children’s Hospital (AU)
- Women's and Children's Health Network (AU)
- Murdoch Children's Research Institute (AU)
- Perth Children's Hospital
- Monash University (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Allergy
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1111/all.16451
- Citations
- 6
- Primary Topic
- Food Allergy and Anaphylaxis Research
- Type
- article
- Field-Weighted Citation Impact
- 2.30